<DOC>
	<DOCNO>NCT00377299</DOCNO>
	<brief_summary>Bipolar disorder ( BD ) common severe psychiatric illness . Drug alcohol abuse common people BD mood disorder associate increased rate hospitalization , violence towards self others , medication non-adherence cognitive impairment . However , study investigate treatment dual-diagnosis patient substance use frequently exclusion criterion clinical trial patient BD . To address need , develop research program explore pharmacotherapy people BD substance related-disorders . A potentially interesting treatment BD citicoline . Some data suggest supplement may stabilize mood , decrease drug use craving , improve memory . We find promising result citicoline patient BD cocaine dependence . In recent year use amphetamine methamphetamine become important public health concern . However , virtually research conduct treatment amphetamine abuse . We propose double-blind placebo control prospective trial citicoline group 60 depress outpatient bipolar disorder , depress phase major depressive disorder amphetamine abuse/dependence , explore safety tolerability citicoline , efficacy mood symptom , stimulant use crave impact cognition . Our goal determine symptom ( e.g . mood , cognition , substance use ) citicoline appear effective estimate effect size future work .</brief_summary>
	<brief_title>A Pilot Study Citicoline add-on Therapy Patients With Bipolar Disorder Major Depressive Disorder Amphetamine Abuse Dependence</brief_title>
	<detailed_description>Sixty outpatient meet inclusion exclusion criterion enrol complete Institutional Review Board ( IRB ) -approved informed consent process . Baseline evaluation include medical psychiatric history , structure clinical interview Diagnostic Statistical Manual ( DSM-IV ) ( SCID ) , mood assessment Inventory Depressive Symptomatology-Self Report ( IDS-C ) , Young Mania Rating Scale ( YMRS ) , cognitive assessment Hopkins Auditory Verbal Learning Test ( HVLT ) ( similar Rey Auditory Verbal Learning Test ( RAVLT ) alternative equivalent version available ) , Stroop computer assessment include Sternberg Memory Task Running Memory Continuous Performance Test . Alternate equivalent version cognitive test , except Stroop , use minimize practice effect repeat administration . Days amount amphetamine substance use assess visit urine drug screen , self-report use timeline follow-back method . Amphetamine , drug , crave assess visual analogue scale . Citicoline placebo add-on therapy give begin one tablet ( 500mg ) /day increase two tablet 1000 mg/day week 2 , three table 1500 mg/day week 4 four tablet 2000 mg/day week 6 .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Cytidine Diphosphate Choline</mesh_term>
	<criteria>Men woman age 1870 year Meeting criterion current major depressive episode ( bipolar I , II , otherwise specify ( NOS ) , depressed phase ) major depressive disorder Structured Clinical Interview Diagnostic Statistical Manual Mental Disorders ( SCID ) duration least 4 week Meeting criterion amphetamine abuse dependence use within 14 day prior baseline No psychotropic medication change within 14 day prior study entry Pregnant nursing woman Current citicoline therapy Active suicidal homicidal ideation plan intent Dementia , mental retardation severe cognitive impairment might interfere informed consent process Currently incarcerate prison jail Severe life threaten medical condition ( e.g . terminal cancer , congestive heart failure )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Amphetamine Abuse</keyword>
	<keyword>Amphetamine Dependence</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Citicoline</keyword>
</DOC>